Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.36 USD | +0.36% | +73.46% | +57.22% |
May. 01 | North American Morning Briefing : Traders Wait for -2- | DJ |
Apr. 30 | Barclays Upgrades Deciphera Pharmaceuticals to Equalweight From Underweight, Price Target is $26 | MT |
Financials (USD)
Sales 2024 * | 202M | Sales 2025 * | 264M | Capitalization | 2.08B |
---|---|---|---|---|---|
Net income 2024 * | -196M | Net income 2025 * | -156M | EV / Sales 2024 * | 10.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.88 x |
P/E ratio 2024 * |
-11.6
x | P/E ratio 2025 * |
-15.3
x | Employees | 355 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.98% |
Latest transcript on Deciphera Pharmaceuticals, Inc.
1 day | +0.36% | ||
1 week | +72.87% | ||
Current month | +0.36% | ||
1 month | +61.22% | ||
3 months | +77.09% | ||
6 months | +111.51% | ||
Current year | +57.22% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 18-05-16 |
Tucker Kelly
DFI | Director of Finance/CFO | 53 | 15-01-31 |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 22-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patricia Allen
BRD | Director/Board Member | 62 | 16-08-31 |
Edward Benz
BRD | Director/Board Member | 78 | 19-06-30 |
Ron Squarer
CHM | Chairman | 57 | 19-12-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 2 M€ | -.--% | ||
0.04% | 237 M€ | +0.96% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 25.36 | +0.36% | 4,689,244 |
24-04-30 | 25.27 | -0.04% | 4,960,411 |
24-04-29 | 25.28 | +72.56% | 50,724,470 |
24-04-26 | 14.65 | +3.31% | 330,362 |
24-04-25 | 14.18 | -3.01% | 527,033 |
Delayed Quote Nasdaq, May 01, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.22% | 2.08B | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- DCPH Stock